Skip to main content

Correction: Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2

The Original Article was published on 17 December 2019

Correction: J Exp Clin Cancer Res 38, 495 (2019)

https://doi.org/10.1186/s13046-019-1488-1

Following publication of the original article [1], an error was identified in Fig. 8; specifically:

  • Fig. 8C: Incorrect image used for migration experiment of exo-miR-NC (bottom left image); correct image is now used.

The corrected figure is given here. The correction does not have any effect on the final conclusions of the paper.

Fig. 8
figure 1

hBMSCs-derived exosomal miR-205 inhibits LNCaP cell proliferation, invasion, and migration and enhances apoptosis. a proliferation of LNCaP cells treated with hBMSCs and miR-205 measured using EdU assay (× 200); b apoptosis of LNCaP cells treated with hBMSCs and miR-205 measured using flow cytometry; Abscissa represents apoptotic cells identified by Annexin V-FITC and ordinate represents dead cells identified by PI; c invasion and migration of LNCaP cells treated with hBMSCs and miR-205 measured using Transwell assay (× 200); d protein band patterns and levels of Ki67, PCNA, MMP-2, MMP-9, Bcl-2, and Bax measured in LNCaP cells treated with hBMSCs and miR-205 determined using western blot analysis; *, p < 0.05. Measurement data were expressed as mean ± standard deviation; comparisons between two groups were analyzed using unpaired t-test; the experiment was repeated 3 times independently

Reference

  1. Jiang S, Mo C, Guo S, et al. Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2. J Exp Clin Cancer Res. 2019;38:495. https://doi.org/10.1186/s13046-019-1488-1.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaopeng Mao.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jiang, S., Mo, C., Guo, S. et al. Correction: Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2. J Exp Clin Cancer Res 41, 206 (2022). https://doi.org/10.1186/s13046-022-02417-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-022-02417-y